Loss of acetylcholine-induced relaxation by M3-receptor activation in mesenteric arteries of spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 2, 1997, Pages 245-252

  Wu, Chin Chen ^a   Chen, Shiu Jen ^a   Yen, Mao Hsiung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Endothelium derived hyperpolarizing factor; M3 receptor; Nitric oxide; Spontaneously hypertensive rats; Wistar Kyoto rats

Indexed keywords

4 AMINOPYRIDINE; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; APAMIN; CALCIMYCIN; CHARYBDOTOXIN; DIPHENYLCARBAMIC ACID 4 CARBOXY 2 NITROPHENYL ESTER; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GLYCERYL TRINITRATE; METHOCTRAMINE; METHYLENE BLUE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; N(G) NITROARGININE; NITRIC OXIDE; PIRENZEPINE; POTASSIUM ION; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; CALCIMYCIN; ENZYME INHIBITORS; HYPERTENSION; IONOPHORES; MALE; MESENTERIC ARTERIES; METHYLENE BLUE; MUSCARINIC AGONISTS; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, MUSCARINIC; RECEPTORS, PURINERGIC P1;

EID: 0030784617     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199708000-00015     Document Type: Article

References (50)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Peach MJ, Loeb AL, Signer HA, Saye JA. Endothelium-derived relaxing factor. Hypertension 1985;7:I94-100.
3. Furchgott RF. Role of endothelium in response of vascular smooth muscle. Circ Res 1983;53:557-73.
4. Vane JR, Änggård EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
5. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 1987;84:9265-9.
7. Greenberg SS, Wilcox DE, Rubanyi GM. Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy. Circ Res 1990;67:1446-52.
8. Myers PR, Minor RL Jr, Guerra R Jr, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990;345:161-3.
9. Chen G, Suzuki H, Weston AH. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 1988;95:1165-74.
10. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93: 515-24.
11. Pinto A, Abraham NG, Mullane KM. Arachidonic acid-induced endothelium-dependent relaxations of canine coronary arteries: contribution of a cytochrome P-450 dependent pathway. J Pharmacol Exp Ther 1987;240:856-63.
12. Guengerich FP. Reactions and significance of cytochrome P-450 enzymes. J Biol Chem 1991;266:10019-22.
13. Gebremedhin R, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Phvsiol 1992;263: H519-25.
14. + channels by cytochrome P-450 inhibitors. J Biol Chem 1992;267:11789-93.
15. + channel in vascular smooth muscles by cytochrome P-450 metabolites of arachidonic acid. Eur J Pharmacol 1993;230:215-21.
16. Furchgott RF, Carvalho MH, Khan MT, Matsunaga K. Evidence for endothelium-dependent vasodilation of resistance vessels by acetylcholine. Blood Vessels 1987;24:145-9.
17. + and calcium channels. Br J Pharmacol 1990;100: 427-34.
18. Wu CC, Chen SJ, Yen MH. Different responses to acetylcholine in the presence of nitric oxide inhibitor in rat aortae and mesenteric arteries. Clin Exp Pharmacol Physiol 1993;20:405-12.
19. Hwa JJ, Ghibaudi L, Williams P, Chatterjee M. Comparison of acetylcholine-dependent relaxation in large and small arteries of rat mesenteric vascular bed. Am J Physiol 1994;266:H952-8.
20. Komori K, Suzuki H. Heterogeneous distribution of muscarinic receptors in the rabbit saphenous artery. Br J Pharmacol 1987;92: 657-64.
21. Simonsen U, Prieto D, Rivera L, Hernandez M, Mulvany MJ, Garcia-Sacristan A. Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries. Br J Pharmacol 1993;109: 998-1007.
22. Ren LM, Nakane T, Chiba S. Muscarinic receptor subtypes mediating vasodilation and vasoconstriction in isolated, perfused simian coronary arteries. J Cardiovasc Pharmacol 1993;22:841-6.
23. Fujii K, Tominaga M, Ohmori S, et al. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res 1992; 70:660-9.
24. Hayakawa H, Hirata Y, Suzuki E, et al. Mechanisms for altered endothelium-dependent vasorelaxation in isolated kidneys from experimental hypertensive rats. Am J Physiol 1993;264:H1535-41.
25. Fujii K, Ohmori S, Tominaga M, et al. Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol 1993;265:H509-16.
26. Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci 1995;88:611-22.
27. Kilbinger H, Halim S, Lambrecht G, Weiler W, Wessler I. Comparison of affinities of muscarinic antagonists to pre- and postjunctional receptors in the guinea-pig ileum. Eur J Pharmacol 1984;103: 313-20.
28. Michel AD, Whiting RL. Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies. Eur J Pharmacol 1988;145:61-6.
29. 3 subtype. Eur J Pharmacol 1988;151:497-500.
30. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 1952;14:48-58.
31. Lambrecht G, Feifel R, Wagner-Röder M, et al. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur J Pharmacol 1989;168:71-80.
32. Barlow RB, Berry KJ, Glenton PAM, Nikolaou NM, Soh KS. A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29°C and in ileum at 29°C and 37°C. Br J Pharmacol 1976;58:613-20.
33. Brown DA, Forward A, Marsh S. Antagonist discrimination between ganglionic and ileal muscarinic receptors. Br J Pharmacol 1980;71:362-4.
34. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
35. Young RH, Ding YA, Lee YM, Yen MH. Cilazapril reverses endothelium-dependent vasodilator response to acetylcholine in mesenteric artery from spontaneously hypertensive rats. Am J Hypertens 1995;8:928-33.
36. van Zwieten PA, Safar M, et al. New insights into the role of endothelial dysfunction in hypertension. J Hypertens 1995;13:713-6.
37. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-42.
38. Waldron GJ, Garland CJ. Contribution of both nitric oxide and a change in membrane potential to acetylcholine-induced relaxation in the rat small mesenteric artery. Br J Pharmacol 1994;112:831-6.
39. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
40. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
41. Rapoport RM, Draznin MB, Murad F. Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 1983;306:174-6.
42. Zygmunt PM, Ryman T, Högestätt ED. Regional differences in endothelium-dependent relaxation in the rat: contribution of nitric oxide and nitric oxide-independent mechanisms. Acta Physiol Scand 1995;155:257-66.
43. +]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol 1993;21:423-9.
44. Wu CC, Bohr DF. Mechanisms of calcium relaxation of vascular smooth muscle. Am J Physiol 1991;261:H1411-6.
45. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 1995;16:23-30.
46. 3 receptor stimulation in guinea-pig coronary artery. Br J Pharmacol 1995;115:717-22.
47. Hendriks MGC, Pfaffendorf M, van Zwieten PA. Characterization of the muscarinic receptor subtype mediating vasodilatation in the rat perfused mesenteric vascular bed preparation. J Auton Pharmacol 1992;12:411-20.
48. Hendriks MGC, Pfaffendorf M, van Zwieten PA. Characterization of the muscarinic receptors in the mesenteric vascular bed of spontaneously hypertensive rats. J Hypertens 1993;11:1329-35.
49. Bruning TA, Hendriks MGC, Chang PC, Kuypers EAP, van Zwieten PA. In vivo characterization of vasodilating muscarinic receptor subtypes in man. Circ Res 1994;74:912-9.
50. Taylor P, Cholinergic agonists. In: Gilman AG, Rail TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. 8th ed. Singapore: Pergamon Press, 1990:122-30.